Skip to main content

Lo Loestrin Fe FDA Approval History

FDA Approved: Yes (First approved October 21, 2010)
Brand name: Lo Loestrin Fe
Generic name: norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate
Dosage form: Tablets
Company: AbbVie Inc.
Treatment for: Birth Control

Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate) is an estrogen/progestin COC indicated for use by women to prevent pregnancy.

Development timeline for Lo Loestrin Fe

DateArticle
Oct 22, 2010Approval Warner Chilcott Announces FDA Approval of New Oral Contraceptive Lo Loestrin Fe

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.